MedPath

ImClone LLC

ImClone LLC logo
🇺🇸United States
Ownership
Subsidiary
Established
1984-01-01
Employees
5K
Market Cap
-
Website
http://www.imclone.com

Clinical Trials

84

Active:79
Completed:4

Trial Phases

3 Phases

Phase 1:42
Phase 3:3
Not Applicable:2

Drug Approvals

1

FDA:1

Drug Approvals

ERBITUX

Approval Date
Jun 22, 2023
FDA

Clinical Trials

Distribution across different clinical trial phases (47 trials with phase data)• Click on a phase to view related trials

Phase 1
42 (89.4%)
Phase 3
3 (6.4%)
Not Applicable
2 (4.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.